BEAM – beam therapeutics inc. (US:NASDAQ)
Stock Stats
News
Bernstein Maintains an Outperform Rating on Beam Therapeutics Inc. (BEAM) [Yahoo! Finance]
Cathie Wood quietly buys $7.27 million of popular tech stock [Yahoo! Finance]
Beam Therapeutics (NASDAQ:BEAM) was given a new $41.00 price target on by analysts at Tudor Pickering.
Beam Therapeutics (NASDAQ:BEAM) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Beam Therapeutics: Pivoting From Platform To Execution Stage [Seeking Alpha]
Form 8-K Beam Therapeutics Inc. For: Jan 31
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: FMR LLC
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: ARK Investment Management LLC
Form 4 Beam Therapeutics Inc. For: Jan 31 Filed by: Bellon Christine
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.